These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12493543)

  • 1. Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography.
    Ogawa M; Hatano K; Kawasumi Y; Ishiwata K; Kawamura K; Ozaki S; Ito K
    Nucl Med Biol; 2003 Jan; 30(1):51-9. PubMed ID: 12493543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay.
    Smith ED; Ariane Vinson N; Zhong D; Berrang BD; Catanzaro JL; Thomas JB; Navarro HA; Gilmour BP; Deschamps J; Carroll FI
    Bioorg Med Chem; 2008 Jan; 16(2):822-9. PubMed ID: 17976996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).
    Kawamoto H; Ozaki S; Itoh Y; Miyaji M; Arai S; Nakashima H; Kato T; Ohta H; Iwasawa Y
    J Med Chem; 1999 Dec; 42(25):5061-3. PubMed ID: 10602690
    [No Abstract]   [Full Text] [Related]  

  • 7. A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one(J-113397), the first non-peptide ORL-1 receptor antagonist.
    De Risi C; Piero Pollini G; Trapella C; Peretto I; Ronzoni S; Giardina GA
    Bioorg Med Chem; 2001 Jul; 9(7):1871-7. PubMed ID: 11425589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent.
    Ogawa M; Hatano K; Kawasumi Y; Wichmann J; Ito K
    Nucl Med Biol; 2001 Nov; 28(8):941-7. PubMed ID: 11711314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Jan; 387(3):R17-8. PubMed ID: 10650183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.
    Yamada S; Kusaka T; Urayama A; Kimura R; Watanabe Y
    Br J Pharmacol; 2003 Aug; 139(8):1462-8. PubMed ID: 12922933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.
    Corboz MR; Rivelli MA; Egan RW; Tulshian D; Matasi J; Fawzi AB; Benbow L; Smith-Torhan A; Zhang H; Hey JA
    Eur J Pharmacol; 2000 Aug; 402(1-2):171-9. PubMed ID: 10940371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase.
    Musachio JL; Flesher JE; Scheffel UA; Rauseo P; Hilton J; Mathews WB; Ravert HT; Dannals RF; Frost JJ
    Nucl Med Biol; 2002 Jul; 29(5):547-52. PubMed ID: 12088724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitussive action of nociceptin in the cat.
    Bolser DC; McLeod RL; Tulshian DB; Hey JA
    Eur J Pharmacol; 2001 Oct; 430(1):107-11. PubMed ID: 11698070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
    Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
    Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-regulated internalization of the opioid receptor-like 1: a confocal study.
    Corbani M; Gonindard C; Meunier JC
    Endocrinology; 2004 Jun; 145(6):2876-85. PubMed ID: 15016723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test.
    Yamamoto T; Shono K; Tanabe S
    J Pharmacol Exp Ther; 2006 Jul; 318(1):206-13. PubMed ID: 16565164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activity of nociceptin/orphanin FQ on capsaicin-induced bronchoconstriction in the guinea-pig.
    Corboz MR; Fernandez X; Egan RW; Hey JA
    Life Sci; 2001 Jul; 69(10):1203-11. PubMed ID: 11508352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.
    Kawamura K; Shiba K; Tsukada H; Nishiyama S; Mori H; Ishiwata K
    Ann Nucl Med; 2006 Jul; 20(6):417-24. PubMed ID: 16922470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices.
    Rominger A; Förster S; Zentner J; Dooley DJ; McKnight AT; Feuerstein TJ; Jackisch R; Vlaskovska M
    Br J Pharmacol; 2002 Feb; 135(3):800-6. PubMed ID: 11834628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS; Marti M; Morari M
    Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.